Clinical benefit of anti-PD-(L)1 immunotherapies in advanced cancer in France: a population-based estimate from 2014 to 2021
| Autor: | Grumberg, V., Cotté, F.-E., Giroux-Leprieur, E., Gaudin, A.-F., Lebbé, C., Borget, I. |
|---|---|
| Zdroj: | In ESMO Open February 2024 9(2) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|